Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 28444181)

Published in J Gerontol A Biol Sci Med Sci on April 21, 2017

Authors

Samuel Golpanian¹^,2, Darcy L DiFede³, Aisha Khan¹, Ivonne Hernandez Schulman¹^,4, Ana Marie Landin¹^,3, Bryon A Tompkins¹^,2, Alan W Heldman¹, Roberto Miki⁴, Bradley J Goldstein¹^,2, Muzammil Mushtaq⁴, Silvina Levis-Dusseau⁴, John J Byrnes⁴, Maureen Lowery⁴, Makoto Natsumeda¹, Cindy Delgado¹, Russell Saltzman¹, Mayra Vidro-Casiano¹, Marietsy V Pujol¹, Moisaniel Da Fonseca¹, Anthony A Oliva³, Geoff Green³, Courtney Premer¹, Audrey Medina³, Krystalenia Valasaki¹, Victoria Florea¹, Erica Anderson⁵, Jill El-Khorazaty⁵, Adam Mendizabal⁵, Pascal J Goldschmidt-Clermont⁴, Joshua M Hare¹^,4

Author Affiliations

1: The Interdisciplinary Stem Cell Institute.
2: Department of Surgery, University of Miami Miller School of Medicine, Florida.
3: Longeveron LLC, Miami, Florida.
4: Department of Medicine, University of Miami Miller School of Medicine, Florida.
5: The Emmes Corporation, Rockville, Maryland.

Associated clinical trials:

AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery. (CRATUS) | NCT02065245

Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes (GARM-W) | NCT03514537

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty | NCT05018767

Articles citing this ↘

21st Century Diseases: Commonly Rare and Rarely Common? Antioxid Redox Signal (2017) 0.75

Articles by these authors ⇆

Randomized Comparison of Allogeneic Vs. Autologous Mesenchymal Stem Cells for Non-lschemic Dilated Cardiomyopathy: POSEIDON-DCM Trial. J Am Coll Cardiol (2016) 1.44

A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant (2013) 0.84

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci (2017) 0.75